Intended Audience: Teams (physicians, NPs, PAs, nurses, pharmacists) specializing in rheumatology

Registration for the AWIR Summit is required to attend this CME session. Rheumatologists will have an opportunity to attend other educational sessions, receive CME, share best practices, and network with their peers. Registration for the Summit should be completed by December 3 to allow for seamless access. Register for the Summit here.

 

During this virtual meeting, experts will discuss practical strategies to improve access to quality rheumatology care across diverse patient populations. With an emphasis on team-based approaches, the faculty will highlight:

• The value of leveraging advanced practice providers and collaborating with primary care physicians
• The importance of diversity in clinical trials for new rheumatology therapies
• The benefits and challenges associated with telehealth/virtual visits (including in rural communities and communities of color)

• Implement best practices that bridge the gaps in healthcare disparities to ensure equitable access to new and emerging therapies for rheumatic conditions
• Evaluate strategies to increase inclusivity in clinical trials to close gaps in data that impact treatment decisions
• Incorporate interprofessional practices and telehealth solutions to increase timely and equitable access to rheumatology care

1. Collaboration With Primary Care for Timely Referrals and Early Care Access: Developing a Team-Based Model
2. Increasing Inclusivity in Clinical Trials: Meeting Communities Where They Are
3. Telehealth and Virtual Strategies: Selecting Optimal Video or Phone-Based Platforms Based on Patient Resources and Needs, and Acknowledging the Telehealth Limitations of Some Communities
4. The Role of Advance Practice Providers in Rheumatology Practices

1. Register using the online form
2. Complete the pre-registration survey
3. Attend the live program in its entirety
4. Complete an online evaluation and post-test
5. Download and/or print a certificate of completion and/or submit CE credits electronically

Instructions to access CME/CE credit options will be provided at the end of the program.

• Hardware: an Internet-enabled computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity
• Software: the installation of software such as GoToWebinar may be required

*PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with commercial interests to disclose:

• Alexis Ogdie, MD, MSCE (Speaker)
  
  Consultant – AbbVie, Amgen, BMS, Celgene, Corrona, Janssen, Lilly, Novartis, Pfizer, Takeda
  Grants / Research Support – Amgen (to Forward), Forward/National Databank for Rheumatic Diseases, NIH/NIAMS, Novartis (to Penn), Pfizer (to Penn), Rheum Research Foundation
  Other Financial or Material Support (royalties, patents, etc.) – Novartis
• Guillermo J Valenzuela, MD (Speaker)
  
  Advisory Board or Panel – AstraZeneca, Boehringer Ingelheim, HORIZON, Janssen, LILLY, Novartis, Pfizer, UCB
  Consultant – AbbVie, Amgen, AstraZeneca, Aurinia, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, HORIZON, Janssen, LILLY, Novartis, Pfizer, Regeneron, SANOFI, UCB
  Grants / Research Support – AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, HORIZON, Janssen, LILLY, Novartis, Pfizer, Regeneron, UCB
  Speakers Bureau or other Promotional Education – Amgen, AstraZeneca, Aurinia, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, HORIZON, Janssen, LILLY, Novartis, SANOFI, UCB
• Grace C Wright, MD, PhD, FACR (Speaker, Moderator)
  
  Advisory Board or Panel – AbbVie, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, Janssen Biotech, Myriad Autoimmune, Novartis, Pfizer, Sanofi Genzyme, UCB
  Consultant – AbbVie, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, Janssen Biotech, Myriad Autoimmune, Novartis, Pfizer, Sanofi Genzyme, UCB
  Speakers Bureau or other Promotional Education – AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Myriad Autoimmune, Novartis, Sanofi Genzyme, UCB
• Ashira Blazer, MD (Speaker)
  
  Consultant – GlaxoSmithKline, Novartis
  Speakers Bureau or other Promotional Education – GlaxoSmithKline
• Gail S Kerr, MD, FRCP(Edin) (Speaker)
  
  Advisory Board or Panel – American College of Rheumatology, AstraZeneca, Bristol-Myers Squibb, FDA, Genentech, GlaxoSmithKline, Horizon, Janssen, Merck, Pfizer, Samumed, Sanofi-Regeneron, Sun, Viela
  Grants / Research Support – AstraZeneca, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Horizon, Janssen, Merck, Novartis, Pfizer, Samumed, Sanofi-Regeneron, Sun, Viela
  Speakers Bureau or other Promotional Education – Aurinia
• Gwenesta B Melton, MD, FACR (Speaker)
  
  Speakers Bureau or other Promotional Education – Amgen, Aurinia, Exagen, MyriadAutoimmune, Pfizer, Sanofi, UCB
• Priya Reddy, MD, FACR (Speaker)
  
  Advisory Board or Panel – Horizon, Janssen, Pfizer
  Grants / Research Support – AbbVie
  Speakers Bureau or other Promotional Education – AbbVie, Amgen, Exagen, Myriad, Pfizer, UCB

The following individuals have no relevant financial relationships with commercial interests to disclose:

• S Sam Lim, MD, MPH (Speaker)
• Annette Sophin, MSMM, PA-C (Reviewer)
• Henry A Solomon, MD, FACP, FACC (Planner)
• Joyce M Knestrick, PhD, CRNP, FAANP (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose.